Results 131 to 140 of about 11,163 (214)

Clinical and Microbiological Characteristics of Candida guilliermondii and Candida fermentati

Clinical and Microbiological Characteristics of Candida guilliermondii and Candida fermentati
長崎大学学位論文 [学位記番号]博（医歯薬）甲第1077号 [学位授与年月日]平成30年6月6日 (2018-06-06)
openaire   +1 more source

<i>Candida guilliermondii</i> endocarditis in a patient with prosthetic mitral valve: a case report. [PDF]

Curr Med Mycol
J K SP, Manju Balasubramaniam G, C P R.
europepmc   +1 more source

Trichosporon asahii and Candida guilliermondii as a Source of Orbital Infection in an Immunocompromised Individual. [PDF]

Cureus
Morcos D, Hardy K, Makovec A, Schill M, Foxworth J.   +4 more
europepmc   +1 more source

Periprosthetic knee infection by Mycobacterium bovis and Candida guilliermondii in the context of a zoonosis: a case report and review of the literature. [PDF]

J Med Case Rep, 2019
Kuner E, Jöckel JA, Orler R, Nüesch R.
europepmc   +1 more source

Diagnosis and Treatment Challenges of Candida guilliermondii in Immunocompromised Patients: A Case Study in a Neutropenic AML Patient. [PDF]

Case Rep Infect Dis
Modi D, Dessureault S, Greene J.
europepmc   +1 more source

The antimicrobial effects of silver nanoparticles obtained through the royal jelly on the yeasts Candida guilliermondii NP-4. [PDF]

Sci Rep
Marutyan S, Karapetyan H, Khachatryan L, Muradyan A, Marutyan S, Poladyan A, Trchounian K.   +6 more
europepmc   +1 more source

Hypersensitivity Pneumonitis Caused by a Home Ultrasonic Humidifier Contaminated with Candida guilliermondii. [PDF]

Intern Med, 2017
Ando A, Hagiya H, Nada T, Kimura K, Waseda K, Rai K, Hanayama Y, Otsuka F.   +7 more
europepmc   +1 more source

<i>Candida guilliermondii</i> fungemia: a 12-year retrospective review of antimicrobial susceptibility patterns at a reference laboratory and tertiary care center. [PDF]

J Clin Microbiol
McHugh JW, Bayless DR, Ranganath N, Stevens RW, Kind DR, Wengenack NL, Shah AS.   +6 more
europepmc   +1 more source

Differential recognition of Candida tropicalis, Candida guilliermondii, Candida krusei, and Candida auris by human innate immune cells. [PDF]

Infect Drug Resist, 2019
Navarro-Arias MJ, Hernández-Chávez MJ, García-Carnero LC, Amezcua-Hernández DG, Lozoya-Pérez NE, Estrada-Mata E, Martínez-Duncker I, Franco B, Mora-Montes HM.   +8 more
europepmc   +1 more source

Polymerase chain reaction assay for specific identification of Candida guilliermondii (Pichia guilliermondii)

Polymerase chain reaction assay for specific identification of Candida guilliermondii (Pichia guilliermondii)
The incidence rates of fungemia caused by Candida guilliermondii have been increasing over the past several years. Although still relatively rare (1.3% of all cases of fungemia in Japan), most cases of C. guilliermondii fungemia occur in patients with cancer or hematological malignancy and their mortality rate is high. As C.
openaire